Biotech Startups
10,023 companies tagged Biotech, with their investors and founders.
0 investors
0 investors
0 investors
Metabolic Solutions Development Company (MSDC) is a drug discovery and development company investigating new molecular targets and developing therapeutics for metabolic diseases linked to age-related mitochondrial dysfunction, particularly insulin resistance and type 2 diabetes.
0 investors
0 investors
A clinical-stage biotech company developing novel drugs based on isotope-selective modulation technology, with patented drug compositions and a proprietary development platform currently in clinical trials.
0 investors
0 investors
0 investors
0 investors
0 investors
0 investors
0 investors
0 investors
Mevion Medical Systems builds compact proton therapy systems, including the MEVION S250 series, used by cancer treatment centers and NCI-designated cancer centers for radiation oncology. The systems are marketed on their small footprint and lower capital and operating costs compared with other proton therapy platforms.
0 investors
0 investors
MiHelper develops a medical device and runs clinical trials in the area of headache and migraine treatment, working with headache neurologists and clinical research specialists. It operates in the medtech and digital health space with a focus on neurology.
0 investors
0 investors
0 investors
0 investors
Microbion develops therapeutics targeting biofilm-associated infections, with a lead candidate (Pravibismane) in clinical development for diabetic foot ulcer, orthopedic implant, and respiratory infections. The company operates in the biotech industry.
0 investors
0 investors
0 investors
0 investors
Microscopy Innovations builds the programmable mPrep ASP automated specimen processors and mPrep specimen and grid capsules for preparing samples and TEM grids for electron microscopy workflows including TEM, vEM, and SEM. Its products serve laboratories doing electron microscopy specimen preparation and immuno-labeling, with capsules that also work with hand-held pipettors.
0 investors